Previous Article | Next Article ![]()
Infection and Immunity, September 1998, p. 4043-4049, Vol. 66, No. 9
Departments of
Bacteriology1 and
Internal Medicine
(II),
Received 29 December 1997/Returned for modification 23 March
1998/Accepted 3 June 1998
The contribution of reactive oxygen intermediates (ROI) and
reactive nitrogen intermediates (RNI) to the killing of Listeria monocytogenes by macrophages activated by addition of spleen
cells from listeria-immune mice plus specific antigen was examined. When macrophages were infected with L. monocytogenes and
then spleen cells were added, there was not as big a difference in listericidal activity between macrophages cultured with normal spleen
cells and those cultured with immune spleen cells as expected. In this
culture system, RNI was mainly involved in the macrophage intracellular
killing. In macrophages first activated and then infected, a
significant level of enhanced killing was observed. Blockade of ROI
production drastically affected the enhanced killing ability, while
inhibition of RNI production had a negligible effect. Thus, the
contributions of ROI and RNI to listericidal mechanisms of macrophages
were different between macrophages activated at pre- and postinfection
stages.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Contributions of Reactive Oxygen Intermediates and
Reactive Nitrogen Intermediates to Listericidal Mechanisms Differ
in Macrophages Activated Pre- and Postinfection
*
Corresponding author. Mailing address: Department of
Bacteriology, Niigata University School of Medicine, 1-757, Asahimachi-dori, Niigata 951-8510, Japan. Phone: (81)25-227-2110. Fax:
(81)25-227-0762. E-mail: sohya{at}med.niigata-u.ac.jp.
Infection and Immunity, September 1998, p. 4043-4049, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|